Co-Diagnostics, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Co-Diagnostics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Co-Diagnostics, Inc. Return On Equity for the quarter ending September 30, 2024 was -55 %, a 38.1% decline year-over-year.
  • Co-Diagnostics, Inc. annual Return On Equity for 2023 was -35.4 %, a 236% decline from 2022.
  • Co-Diagnostics, Inc. annual Return On Equity for 2022 was -10.5 %, a 129% decline from 2021.
  • Co-Diagnostics, Inc. annual Return On Equity for 2021 was 36.8 %, a 62.2% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -35.4 -24.9 -236% Jan 1, 2023 Dec 31, 2023
2022 -10.5 -47.3 -129% Jan 1, 2022 Dec 31, 2022
2021 36.8 -60.6 -62.2% Jan 1, 2021 Dec 31, 2021
2020 97.5 +258 Jan 1, 2020 Dec 31, 2020
2019 -161 +712 +81.6% Jan 1, 2019 Dec 31, 2019
2018 -872 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.